Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | JAK3 |
| Variant | F666L |
| Impact List | missense |
| Protein Effect | gain of function - predicted |
| Gene Variant Descriptions | JAK3 F666L lies within protein kinase domain 1 of the Jak3 protein (UniProt.org). F666L (corresponding to F662L in mouse) results in cytokine-independent proliferation in cell culture (PMID: 25855603), and therefore, is predicted to lead to a gain of Jak3 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
JAK3 mutant JAK3 act mut JAK3 F666L |
| Transcript | NM_000215.4 |
| gDNA | chr19:g.17835134A>G |
| cDNA | c.1996T>C |
| Protein | p.F666L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000215 | chr19:g.17835134A>G | c.1996T>C | p.F666L | RefSeq | GRCh38/hg38 |
| XM_047438786.1 | chr19:g.17835134A>G | c.1996T>C | p.F666L | RefSeq | GRCh38/hg38 |
| NM_000215.3 | chr19:g.17835134A>G | c.1996T>C | p.F666L | RefSeq | GRCh38/hg38 |
| NM_000215.4 | chr19:g.17835134A>G | c.1996T>C | p.F666L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|